Therapies on the horizon for childhood acute lymphoblastic leukemia.
about
The promise of Janus kinase inhibitors in the treatment of hematological malignancies.Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.Therapeutic targeting of CK2 in acute and chronic leukemias.Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.
P2860
Therapies on the horizon for childhood acute lymphoblastic leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapies on the horizon for childhood acute lymphoblastic leukemia.
@en
type
label
Therapies on the horizon for childhood acute lymphoblastic leukemia.
@en
prefLabel
Therapies on the horizon for childhood acute lymphoblastic leukemia.
@en
P2860
P1476
Therapies on the horizon for childhood acute lymphoblastic leukemia.
@en
P2093
William L Carroll
P2860
P356
10.1097/MOP.0000000000000293
P577
2015-11-14T00:00:00Z